In addition, Santanam U et al. reported that miR-29a was upregulated in indolent human B-cell chronic lymphocytic leukemia (B-CLL) as compared with aggressive B-CLL and normal CD19+ B cells [15]. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.